3.52
전일 마감가:
$3.46
열려 있는:
$3.47
하루 거래량:
43,132
Relative Volume:
0.08
시가총액:
$1.10B
수익:
$563.46M
순이익/손실:
$27.92M
주가수익비율:
36.51
EPS:
0.0964
순현금흐름:
$-146.33M
1주 성능:
+6.67%
1개월 성능:
-3.56%
6개월 성능:
-27.12%
1년 성능:
-57.18%
Alvotech Stock (ALVO) Company Profile
Compare ALVO vs TAK, ZTS, TEVA, HLN, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
ALVO
Alvotech
|
3.515 | 1.08B | 563.46M | 27.92M | -146.33M | 0.0964 |
|
TAK
Takeda Pharmaceutical Co Adr
|
16.64 | 52.51B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
113.04 | 48.01B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
35.64 | 40.70B | 17.52B | 1.58B | 1.06B | 1.3428 |
|
HLN
Haleon Plc Adr
|
9.295 | 41.69B | 14.54B | 2.22B | 2.58B | 0.4871 |
|
UTHR
United Therapeutics Corp
|
575.49 | 24.21B | 3.18B | 1.33B | 1.04B | 27.90 |
Alvotech Stock (ALVO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-09 | 개시 | Barclays | Underweight |
| 2025-11-04 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2025-10-14 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2025-09-23 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2025-02-14 | 개시 | UBS | Buy |
| 2024-01-29 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2023-10-20 | 업그레이드 | Citigroup | Sell → Neutral |
| 2023-09-21 | 개시 | Barclays | Equal Weight |
| 2022-09-07 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-09-06 | 다운그레이드 | Citigroup | Buy → Sell |
| 2022-07-26 | 개시 | Citigroup | Buy |
모두보기
Alvotech 주식(ALVO)의 최신 뉴스
Alvotech Announces General Counsel Transition After Six-Year Tenure - TipRanks
[6-K] Alvotech Current Report (Foreign Issuer) | ALVO SEC FilingForm 6-K - Stock Titan
Will Alvotech's (ALVO) Legal Transition and Executive Move to Reykjavik Quietly Reframe Its Governance Story? - simplywall.st
Earnings Preview: Alvotech to Report Financial Results Post-market on May 06 - 富途牛牛
Alvotech Announces a Change in its Executive Team - The Manila Times
Alvotech : General MeetingALVOTECH - marketscreener.com
Alvotech (ALVO) to Release Quarterly Earnings on Wednesday - MarketBeat
Alvotech (NASDAQ:ALVO) Trading 7.1% HigherStill a Buy? - MarketBeat
Why is ALVO stock rising pre-market today? - MSN
Alvotech’s AVT03 approved by European Commission as biosimilar to Prolia and Xgeva - MSN
Dr Reddy's, Alvotech join hands to co-develop, manufacture & commercialise biosimilar of Merck's blockbuster drug Keytruda - MSN
Alvotech CCO Anil Okay steps down to become Adalvo CEO - MSN
Alvotech stock slides as FDA issues CRL for AVT05, company cuts EBITDA outlook - msn.com
Alvotech (ALVO) Valuation Gap Under Review After Mixed Share Performance And Biosimilar Pipeline Progress - Yahoo Finance
Alvotech to Report Financial Results for the First Quarter of 2026 - marketscreener.com
Alvotech to Announce First Quarter 2026 Financial Results and Host Webcast on May 7, 2026 - Quiver Quantitative
Quant snapshot: Micron, Babcock & Wilcox lead strong buys as Fold Holdings, Alvotech lag - MSN
Alvotech : Inside Information / Ad Hoc InformationALVOTECH - marketscreener.com
Alvotech (NASDAQ:ALVO) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Here’s What the Street Thinks About Alvotech (ALVO) - Insider Monkey
Morgan Stanley Upgrades Alvotech (ALVO) - MSN
Wall Street Zen Upgrades Alvotech (NASDAQ:ALVO) to Hold - MarketBeat
Alvotech (NASDAQ:ALVO) Sees Significant Increase in Short Interest - MarketBeat
Alvotech stock (LU2557688560): Why does its biosimilar pipeline now matter more for U.S. investors? - AD HOC NEWS
Cash per share of Alvotech – DUS:Z45 - TradingView — Track All Markets
Alvotech Looks To Make Good On Two-Year Bet - Citeline News & Insights
ALVO SEC FilingsAlvotech 10-K, 10-Q, 8-K Forms - Stock Titan
ALVO Technical Analysis & Stock Price Forecast - Intellectia AI
Alvotech: Improving Fundamentals Signal Potential Bottom For This Biosimilar Player (ALVO) - Seeking Alpha
Retail Trends: Whats the outlook for Alvotech Equity Warrants sector2026 Snapshot & Safe Entry Trade Reports - baoquankhu1.vn
Alvotech’s Price Rises But Technical Signals Turn Bearish - Bitget
Performance Recap: Is Alvotech a top pick in the sector2026 Trade Ideas & Long-Term Growth Plans - baoquankhu1.vn
Why Is Alvotech (ALVOW) Stock Down Today? - Meyka
Alvotech stock: Biosimilar innovator with global growth potential - AD HOC NEWS
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Alvotech (NASDAQ:ALVO) Stock Price Down 9.5%Here's What Happened - MarketBeat
Alvotech Plummets 9.5% Amid Market Volatility and Sector Uncertainty - Bitget
Published on: 2026-04-07 05:57:03 - baoquankhu1.vn
Alvotech (NASDAQ:ALVO) Trading Up 7.2%Here's What Happened - MarketBeat
ETFs Investing in Alvotech Stocks - TradingView
Institution Moves: Is Alvotech stock overvalued or fairly pricedMarket Movers & Weekly High Return Forecasts - baoquankhu1.vn
Alvotech (NASDAQ:ALVO) Stock Rating Lowered by Wall Street Zen - MarketBeat
ALVO Should I Buy - Intellectia AI
ALVO Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Alvotech (ALVO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):